{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:44:44Z","timestamp":1793263484675,"version":"4.5.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi221246-4\"><jats:title>Importance<\/jats:title><jats:p>A discrepancy on current guidelines and clinical practice exists regarding routine imaging surveillance after mastectomy, mainly regarding the lack of adequate evidence for imaging in this setting.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221246-5\"><jats:title>Objective<\/jats:title><jats:p>To investigate the usefulness of imaging surveillance in terms of cancer detection and interval cancer rates after mastectomy with or without reconstruction for patients with prior breast cancer.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221246-6\"><jats:title>Data Sources<\/jats:title><jats:p>A comprehensive literature search was conducted in 3 electronic databases\u2014PubMed, ISI Web of Science, and Scopus\u2014without year restriction. References from relevant reviews and eligible studies were also manually searched.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221246-7\"><jats:title>Study Selection<\/jats:title><jats:p>Eligible studies were defined as those conducting surveillance imaging (mammography, ultrasonography, or magnetic resonance imaging [MRI]) of patients with prior breast cancer after mastectomy with or without reconstruction that presented adequate data to calculate cancer detection rates for each surveillance method.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221246-8\"><jats:title>Data Extraction and Synthesis<\/jats:title><jats:p>Independent data extraction by 2 investigators with consensus on discrepant results was performed. A quality assessment of studies was performed using the QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies\u20132) template. The generalized linear mixed model framework with both fixed-effects and random-effects models was used to meta-analyze the proportion of cases across studies including 3 variables: surveillance method, reconstruction after mastectomy, and surveillance measure.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221246-9\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Three outcome measures were calculated for each eligible study and each surveillance imaging method within studies: overall cancer detection (defined as ipsilateral cancer, both palpable and nonpalpable) rate per 1000 examinations, clinically occult (nonpalpable) cancer detection rate per 1000 examinations, and interval cancer rate per 1000 examinations.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221246-10\"><jats:title>Results<\/jats:title><jats:p>In total, 16 studies were eligible for the meta-analysis. The pooled overall cancer detection rates per 1000 examinations were 1.86 (95% CI, 1.05-3.30) for mammography, 2.66 (95% CI, 1.48-4.76) for ultrasonography, and 5.17 (95% CI, 1.49-17.75) for MRI. For mastectomy without reconstruction, the rate of clinically occult (nonpalpable) cancer per 1000 examinations (2.96; 95% CI, 1.38-6.32) and the interval cancer rate per 1000 examinations (3.73; 95% CI, 0.84-3.98) were lower than the overall cancer detection rate (including both palpable and nonpalpable lesions) per 1000 examinations (6.41; 95% CI, 3.09-13.25) across all imaging modalities. The interval cancer rate per 1000 examinations for mastectomy with reconstruction (3.73; 95% CI, 0.41-2.73) was comparable to the pooled cancer detection rate per 1000 examinations (4.73; 95% CI, 2.32-9.63) across all imaging modalities. In all clinical scenarios and imaging modalities, lower rates of clinically occult cancer compared with cancer detection rates were observed.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi221246-11\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>Lower detection rates of clinically occult\u2014compared with overall\u2014cancer across all 3 imaging modalities challenge the use of imaging surveillance after mastectomy, with or without reconstruction. Findings suggest that imaging surveillance in this context is unnecessary in clinical practice, at least until further studies demonstrate otherwise. Future studies should consider using the clinically occult cancer detection rate as a more clinically relevant measure in this setting.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.44212","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T16:32:19Z","timestamp":1669912339000},"page":"e2244212","source":"Crossref","is-referenced-by-count":28,"title":["Yield of Surveillance Imaging After Mastectomy With or Without Reconstruction for Patients With Prior Breast Cancer"],"prefix":"10.1001","volume":"5","author":[{"given":"Daniel","family":"Smith","sequence":"first","affiliation":[{"name":"Clinical Epidemiology and Biostatistics, School of Medical Sciences, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setara","family":"Sepehr","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Medicine and Health, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Karakatsanis","sequence":"additional","affiliation":[{"name":"Department of Surgical Sciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Strand","sequence":"additional","affiliation":[{"name":"Breast Radiology, Karolinska University Hospital, Solna, Sweden"},{"name":"Department of Oncology-Pathology, Karolinska Institute, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Valachis","sequence":"additional","affiliation":[{"name":"Department of Oncology, Faculty of Medicine and Health, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"issue":"1","key":"zoi221246r1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10549-022-06551-1","article-title":"Trends in surgery and adjuvant treatment for early-stage breast cancer: a population-based study in Queensland, Australia.","volume":"193","author":"Youl","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"zoi221246r2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamasurg.2014.2895","article-title":"Nationwide trends in mastectomy for early-stage breast cancer.","volume":"150","author":"Kummerow","year":"2015","journal-title":"JAMA Surg"},{"issue":"2","key":"zoi221246r3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10549-022-06564-w","article-title":"Trends in surgical treatment of early-stage breast cancer reveal decreasing mastectomy use between 2003 and 2016 by age, race, and rurality.","volume":"193","author":"Roberson","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"13","key":"zoi221246r4","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/bjs.10951","article-title":"Nationwide population-based study of trends and regional variation in breast-conserving treatment for breast cancer.","volume":"105","author":"van Maaren","year":"2018","journal-title":"Br J Surg"},{"key":"zoi221246r5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.breast.2018.02.003","article-title":"Mastectomy patterns, but not rates, are changing in the treatment of early breast cancer: experience of a single European institution on 2315 consecutive patients.","volume":"39","author":"Fancellu","year":"2018","journal-title":"Breast"},{"issue":"4","key":"zoi221246r6","doi-asserted-by":"publisher","first-page":"e539","DOI":"10.1016\/j.clbc.2017.12.013","article-title":"Review of factors influencing women\u2019s choice of mastectomy versus breast conserving therapy in early stage breast cancer: a systematic review.","volume":"18","author":"Gu","year":"2018","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"zoi221246r7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.amjsurg.2016.08.020","article-title":"Trends in mastectomy and reconstruction for breast cancer; a twelve year experience from a tertiary care center.","volume":"212","author":"Chang","year":"2016","journal-title":"Am J Surg"},{"issue":"9","key":"zoi221246r8","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1200\/JCO.2013.52.2284","article-title":"Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States.","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi221246r9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12955-017-0779-5","article-title":"Intensive follow-up for women with breast cancer: review of clinical, economic and patient\u2019s preference domains through evidence to decision framework.","volume":"15","author":"Lafranconi","year":"2017","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"zoi221246r10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001768.pub3","article-title":"Follow-up strategies for women treated for early breast cancer.","volume":"2016","author":"Moschetti","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"zoi221246r11","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"issue":"7","key":"zoi221246r12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1200\/JCO.2012.45.9859","article-title":"Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.","volume":"31","author":"Khatcheressian","year":"2013","journal-title":"J Clin Oncol"},{"issue":"11S","key":"zoi221246r14","doi-asserted-by":"publisher","first-page":"S403","DOI":"10.1016\/j.jacr.2020.09.009","article-title":"ACR Appropriateness Criteria imaging after mastectomy and breast reconstruction.","volume":"17","author":"Heller","year":"2020","journal-title":"J Am Coll Radiol"},{"issue":"4","key":"zoi221246r15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jamcollsurg.2020.01.006","article-title":"Assessing the utility of post-mastectomy imaging after breast reconstruction.","volume":"230","author":"Shammas","year":"2020","journal-title":"J Am Coll Surg"},{"issue":"1","key":"zoi221246r16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1148\/radiol.2018172783","article-title":"Use of screening mammography to detect occult malignancy in autologous breast reconstructions: a 15-year experience.","volume":"289","author":"Noroozian","year":"2018","journal-title":"Radiology"},{"issue":"10","key":"zoi221246r17","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1245\/s10434-010-1087-z","article-title":"Impact of US surveillance on detection of clinically occult locoregional recurrence after mastectomy for breast cancer.","volume":"17","author":"Kim","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"15","key":"zoi221246r18","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting.","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"zoi221246r19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2214\/AJR.19.21640","article-title":"The role of breast MRI in detecting asymptomatic recurrence after therapeutic mastectomy.","volume":"215","author":"Chapman","year":"2020","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"zoi221246r20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10549-018-05077-9","article-title":"Yield of surveillance magnetic resonance imaging after bilateral mastectomy and reconstruction: a retrospective cohort study.","volume":"174","author":"Golan","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"52","key":"zoi221246r21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009244","article-title":"Ultrasound for postoperative surveillance after mastectomy in patients with breast cancer: a retrospective study.","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"zoi221246r22","first-page":"282","article-title":"The follow-up of post-mastectomy patients: should the ipsilateral side be assessed with both mammogram and ultrasound?","volume":"71","author":"Radhika","year":"2016","journal-title":"Med J Malaysia"},{"issue":"10","key":"zoi221246r23","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1245\/s10434-014-3913-1","article-title":"Screening mammography following autologous breast reconstruction: an unnecessary effort.","volume":"21","author":"Freyvogel","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"zoi221246r24","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1245\/s10434-013-3020-8","article-title":"Value of ultrasound for postoperative surveillance of Asian patients with history of breast cancer surgery: a single-center study.","volume":"20","author":"Suh","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"zoi221246r25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ejrad.2012.10.007","article-title":"US screening for detection of nonpalpable locoregional recurrence after mastectomy.","volume":"82","author":"Lee","year":"2013","journal-title":"Eur J Radiol"},{"issue":"3","key":"zoi221246r26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1258\/ar.2011.110597","article-title":"Value of the US BI-RADS final assessment following mastectomy: BI-RADS 4 and 5 lesions.","volume":"53","author":"Gweon","year":"2012","journal-title":"Acta Radiol"},{"issue":"2","key":"zoi221246r27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/000313481107700217","article-title":"Breast MRI after bilateral mastectomy: is it indicated?","volume":"77","author":"Vanderwalde","year":"2011","journal-title":"Am Surg"},{"issue":"2","key":"zoi221246r28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1148\/radiol.2482071635","article-title":"Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions.","volume":"248","author":"Lee","year":"2008","journal-title":"Radiology"},{"issue":"1","key":"zoi221246r29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1148\/radiol.2241010061","article-title":"Mammographic screening of TRAM flap breast reconstructions for detection of nonpalpable recurrent cancer.","volume":"224","author":"Helvie","year":"2002","journal-title":"Radiology"},{"issue":"5","key":"zoi221246r30","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2214\/ajr.161.5.8273633","article-title":"Mammographic surveillance of breast cancer patients: should the mastectomy site be imaged?","volume":"161","author":"Fajardo","year":"1993","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"zoi221246r31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1148\/radiology.188.2.8327698","article-title":"Breast cancer recurrence after mastectomy: diagnosis with mammography and US.","volume":"188","author":"Rissanen","year":"1993","journal-title":"Radiology"},{"key":"zoi221246r32","author":"Stevens","year":"1969","journal-title":"Cancer"},{"issue":"3","key":"zoi221246r33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/tbj.13603","article-title":"Is asymptomatic surveillance beneficial after standard treatment? a 10-year survival analysis of recurrent BC patients by detection method of recurrence.","volume":"26","author":"Lee","year":"2020","journal-title":"Breast J"},{"issue":"7003","key":"zoi221246r34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","article-title":"Absence of evidence is not evidence of absence.","volume":"311","author":"Altman","year":"1995","journal-title":"BMJ"},{"issue":"2","key":"zoi221246r35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10549-020-05637-y","article-title":"Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis.","volume":"181","author":"Haas","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"zoi221246r36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.breast.2020.11.007","article-title":"Breast ultrasound in breast cancer surveillance; incremental cancers found at what cost?","volume":"54","author":"Bromley","year":"2020","journal-title":"Breast"},{"issue":"1","key":"zoi221246r37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1148\/radiol.2020191691","article-title":"Supplemental breast US screening in women with a personal history of breast cancer: a matched cohort study.","volume":"295","author":"Kim","year":"2020","journal-title":"Radiology"},{"issue":"2","key":"zoi221246r39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1148\/radiol.2020201854","article-title":"Imaging surveillance of breast cancer survivors with digital mammography versus digital breast tomosynthesis.","volume":"298","author":"Bahl","year":"2021","journal-title":"Radiology"},{"issue":"2","key":"zoi221246r40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1148\/radiol.2021204581","article-title":"Digital mammography and breast tomosynthesis performance in women with a personal history of breast cancer, 2007-2016.","volume":"300","author":"Lee","year":"2021","journal-title":"Radiology"},{"key":"zoi221246r38","first-page":"21","volume-title":"ACR BI-RADS Atlas, Breast Imaging Reporting and Data System","author":"Sickles","year":"2013","edition":"5th ed"},{"key":"zoi221246r13","unstructured":"National Comprehensive Cancer Network. Breast cancer (version 4, 2022). Accessed October 3, 2022. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2799117\/smith_2022_oi_221246_1669142013.75867.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T16:32:24Z","timestamp":1669912344000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2799117"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.44212","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]}}}